Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
T PaulsenC Tropé

Abstract

The aim of this study was to study the impact of hospital level and surgical skill on short-term survival of advanced ovarian, tubal, and peritoneal cancer patients in a prospective population-based study. All 198 women with a diagnosis of advanced epithelial invasive ovarian, tubal, and peritoneal cancer in Norway who underwent surgery during 2002 were included in this study. The data were derived from notifications to the Norwegian Cancer Registry and from medical, surgical, and histopathologic records. The hospitals were grouped into teaching and nonteaching hospitals (NTH), and the operating physicians were classified according to specialty (specialist gynecologist, gynecologist, and surgeon). The follow-up period was from 455 to 820 days. The short-term survival at 450 days was 79% for women operated at teaching hospitals (TH) and 62% at NTH (P= 0.02). After simultaneous adjustment for seven prognostic factors and residual disease, the risk of death within 600 days at NTH was unchanged compared to TH, hazard ratio 1.83. The women operated on by specialist compared to general gynecologists had a 20% increased short-term survival (P < 0.0001). TH and specialist gynecologists achieved better short-term survival of patients op...Continue Reading

References

Nov 1, 1992·Gynecologic Oncology·S M EisenkopH J Wang
Jan 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S HarveiF Langmark
Jan 1, 1997·Gynecologic Oncology·J P CurtinW J Hoskins
Mar 12, 1998·International Journal of Cancer. Journal International Du Cancer·T BjørgeC G Tropé
Nov 5, 1999·British Journal of Obstetrics and Gynaecology·E J JunorJ Young
Sep 14, 2000·Gynecologic Oncology·A L Covens
Dec 19, 2001·British Journal of Cancer·A OlaitanJ Murdoch
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert E BristowF J Montz
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Solveig TingulstadFinn Egil Skjeldestad
Sep 10, 2002·Gynecologic Oncology·Paul M FlynnUNKNOWN Scottish Gynaecological Cancer Trials Group
Nov 15, 2002·International Journal of Cancer. Journal International Du Cancer·Salla KumpulainenRisto Sankila
Sep 10, 2003·Obstetrics and Gynecology·Solveig TingulstadBjørn Hagen
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·B Sorbe
Dec 25, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·T PaulsenS Tretli

❮ Previous
Next ❯

Citations

Nov 23, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Nils BolstadJohan Bjerner
Mar 13, 2008·Journal of the National Cancer Institute·Flora VernooijYolanda van der Graaf
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Elisabetta BandieraAntonella Ravaggi
Jul 16, 2010·BMC Health Services Research·Jon H FivaMarte Rønning
Aug 28, 2009·Annals of Surgical Oncology·Robert E BristowDeborah K Armstrong
Jul 30, 2014·Iranian Red Crescent Medical Journal·Farah FarzanehTahereh Ashrafgangoi
Jun 7, 2011·Expert Opinion on Medical Diagnostics·Ingegerd Hellstrom, Karl Erik Hellstrom
Jul 24, 2012·Journal of Minimally Invasive Gynecology·Alysson ZanattaLuciano Gibran
May 30, 2012·Obstetrics and Gynecology Clinics of North America·Clare Reade, Laurie Elit
Apr 18, 2012·Gynecologic Oncology·Yin Ling WooHeather O Dickinson
Dec 21, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Aleksandra Gentry-Maharaj, Usha Menon
Sep 25, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C FotopoulouJ Sehouli
Jun 29, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L VerleyeA G J van der Zee
Oct 6, 2009·Gynecologic Oncology·Flora VernooijA Peter M Heintz
Nov 3, 2009·Gynecologic Oncology·Richard G MooreRobert C Bast
Oct 2, 2009·Lancet·Bryan T HennessyMaurie Markman
Jan 13, 2009·Gynecologic Oncology·Flora VernooijYolanda van der Graaf
Sep 20, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·S M Crawford, P J Brunskill
Apr 13, 2011·International Journal of Cancer. Journal International Du Cancer·Yongjung ParkHyon-Suk Kim
Dec 8, 2010·Proteomics. Clinical Applications·Estrid HøgdallClaus Høgdall
Oct 16, 2012·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·J KaijserD Timmerman
Feb 11, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Carsten L Fagö-OlsenBent Ottesen
Apr 1, 2009·Seminars in Oncology·Carolyn Krasner, Linda Duska
Jul 16, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elena-Ioana BraicuChristina Fotopoulou
Dec 18, 2013·Gynecologic Oncology·Jeff F LinScott D Richard
Jul 28, 2016·Gynecologic Oncology·Giovanni D Aletti, William A Cliby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.